BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1463 related articles for article (PubMed ID: 22169927)

  • 1. Fabrication and evaluation of poly(epsilon-caprolactone)/silk fibroin blend nanofibrous scaffold.
    Lim JS; Ki CS; Kim JW; Lee KG; Kang SW; Kweon HY; Park YH
    Biopolymers; 2012 May; 97(5):265-75. PubMed ID: 22169927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen-based biomimetic nanofibrous scaffolds: preparation and characterization of collagen/silk fibroin bicomponent nanofibrous structures.
    Yeo IS; Oh JE; Jeong L; Lee TS; Lee SJ; Park WH; Min BM
    Biomacromolecules; 2008 Apr; 9(4):1106-16. PubMed ID: 18327908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomimetic nanofibrous scaffolds: preparation and characterization of chitin/silk fibroin blend nanofibers.
    Park KE; Jung SY; Lee SJ; Min BM; Park WH
    Int J Biol Macromol; 2006 May; 38(3-5):165-73. PubMed ID: 16581120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and cytocompatibility study of poly (epsilon-caprolactone)/silk sericin nanofibrous scaffolds].
    Li H; Li L; Qian Y; Cai K; Lu Y; Zhong L; Liu W; Yang L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):305-9. PubMed ID: 21604491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrospun poly (ɛ-caprolactone)/silk fibroin core-sheath nanofibers and their potential applications in tissue engineering and drug release.
    Li L; Li H; Qian Y; Li X; Singh GK; Zhong L; Liu W; Lv Y; Cai K; Yang L
    Int J Biol Macromol; 2011 Aug; 49(2):223-32. PubMed ID: 21565216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chitin/silk fibroin nanofibrous bicomponent structures on interaction with human epidermal keratinocytes.
    Yoo CR; Yeo IS; Park KE; Park JH; Lee SJ; Park WH; Min BM
    Int J Biol Macromol; 2008 May; 42(4):324-34. PubMed ID: 18243300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrospun silk fibroin/poly(lactide-co-ε-caprolactone) nanofibrous scaffolds for bone regeneration.
    Wang Z; Lin M; Xie Q; Sun H; Huang Y; Zhang D; Yu Z; Bi X; Chen J; Wang J; Shi W; Gu P; Fan X
    Int J Nanomedicine; 2016; 11():1483-500. PubMed ID: 27114708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of self-assembled nanofibrous silk/polycaprolactone layer on the osteoconductivity and mechanical properties of biphasic calcium phosphate scaffolds.
    Roohani-Esfahani SI; Lu ZF; Li JJ; Ellis-Behnke R; Kaplan DL; Zreiqat H
    Acta Biomater; 2012 Jan; 8(1):302-12. PubMed ID: 22023750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically improved nanofibrous scaffolds for cardiac tissue engineering.
    Bhaarathy V; Venugopal J; Gandhimathi C; Ponpandian N; Mangalaraj D; Ramakrishna S
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():268-77. PubMed ID: 25280706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of hyaluronan to regulate protein adsorption and cell infiltration in nanofibrous scaffolds.
    Li L; Qian Y; Jiang C; Lv Y; Liu W; Zhong L; Cai K; Li S; Yang L
    Biomaterials; 2012 Apr; 33(12):3428-45. PubMed ID: 22300743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gradient nanofibrous chitosan/poly ɛ-caprolactone scaffolds as extracellular microenvironments for vascular tissue engineering.
    Du F; Wang H; Zhao W; Li D; Kong D; Yang J; Zhang Y
    Biomaterials; 2012 Jan; 33(3):762-70. PubMed ID: 22056285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocomposite nanofibrous strategies for the controlled release of biomolecules for skin tissue regeneration.
    Gandhimathi C; Venugopal JR; Bhaarathy V; Ramakrishna S; Kumar SD
    Int J Nanomedicine; 2014; 9():4709-22. PubMed ID: 25336949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nanofiber content on bone regeneration of silk fibroin/poly(ε-caprolactone) nano/microfibrous composite scaffolds.
    Kim BS; Park KE; Kim MH; You HK; Lee J; Park WH
    Int J Nanomedicine; 2015; 10():485-502. PubMed ID: 25624762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and biocompatibility of electrospinning heparin-modified silk fibroin nanofibers.
    Wang S; Zhang Y; Wang H; Dong Z
    Int J Biol Macromol; 2011 Mar; 48(2):345-53. PubMed ID: 21182858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vivo degradation of controlled biodegradability of electrospun silk fibroin nanofiber mats.
    Kim JH; Park CH; Lee OJ; Lee JM; Kim JW; Park YH; Ki CS
    J Biomed Mater Res A; 2012 Dec; 100(12):3287-95. PubMed ID: 22733605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrospun silk fibroin-hydroxybutyl chitosan nanofibrous scaffolds to biomimic extracellular matrix.
    Zhang K; Qian Y; Wang H; Fan L; Huang C; Mo X
    J Biomater Sci Polym Ed; 2011; 22(8):1069-82. PubMed ID: 20615313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional vascularization of electrospun PCL/collagen-blend nanofibrous scaffolds in vivo.
    Klumpp D; Rudisile M; Kühnle RI; Hess A; Bitto FF; Arkudas A; Bleiziffer O; Boos AM; Kneser U; Horch RE; Beier JP
    J Biomed Mater Res A; 2012 Sep; 100(9):2302-11. PubMed ID: 22508579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of nanofibrous scaffolds containing gum tragacanth/poly (ε-caprolactone) for application as skin scaffolds.
    Ranjbar-Mohammadi M; Bahrami SH
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():71-9. PubMed ID: 25579898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrospun homogeneous silk fibroin/poly (ɛ-caprolactone) nanofibrous scaffolds by addition of acetic acid for tissue engineering.
    Zhu J; Luo J; Zhao X; Gao J; Xiong J
    J Biomater Appl; 2016 Sep; 31(3):421-37. PubMed ID: 27422715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of silk fibroin blended P(LLA-CL) nanofibrous scaffolds for tissue engineering.
    Zhang K; Wang H; Huang C; Su Y; Mo X; Ikada Y
    J Biomed Mater Res A; 2010 Jun; 93(3):984-93. PubMed ID: 19722280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.